Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494649 · ClinicalTrials.gov registry record · NA
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
A NA study of Hypersensitivity and Dentinal Sensitivity, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT01494649 is a NA study of Hypersensitivity and Dentinal Sensitivity that has completed, run by GlaxoSmithKline. The registered enrollment target is 118 participants, below the 170-participant average among 8 other Hypersensitivity trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01494649, a NA study of Hypersensitivity and Dentinal Sensitivity, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot study to determine the ability of a stannous fluoride containing toothpaste to provide immediate and short term relief from dentine Hypersensitivity compared to a control toothpaste.
Conditions Studied
Interventions
- DRUG Negative Control Toothpaste
- DRUG Test Toothpaste
Study Locations (1)
Nevada
- BioSci Research America, Inc. - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01494649
The ClinicalTrials.gov registry entry for NCT01494649 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 8 other Hypersensitivity trials with a reported enrollment target (31% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypersensitivity appearing as the primary indexed condition, and to 2 interventions - of which Negative Control Toothpaste is the first listed.
NCT01494649 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT01494649 about?
NCT01494649 is a clinical study titled "Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity". A pilot study to determine the ability of a stannous fluoride containing toothpaste to provide immediate and short term relief from dentine Hypersensitivity compared to a control toothpaste.
What is the current status of trial NCT01494649?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2011-09. Estimated completion is 2011-09.
What conditions does trial NCT01494649 study?
This clinical trial studies the following conditions: Hypersensitivity, Dentinal Sensitivity.
What interventions are being tested in trial NCT01494649?
The interventions under investigation include: Negative Control Toothpaste (DRUG), Test Toothpaste (DRUG).
Who is sponsoring clinical trial NCT01494649?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01494649 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study
COMPLETED · NA
-
Asthma Data Innovation Demonstration Project
COMPLETED · NA
-
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
RECRUITING
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
-
Oral Bacteria and Allergic Disease in Children
COMPLETED
-
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.